Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle-income countries, are likely to restrict the market growth.

Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.

FREE Sample Research Report@ https://marketstatsreport.com/epilepsy-drugs-market-global-demand-growth-potential-opportunity-outlook-2021/#REPORT-DESCRIPTION

Key Topics Covered in the Report

• Worldwide Epilepsy Drugs Market Analysis (2013 – 2021)
• Worldwide Epilepsy Drugs Market Share (2013 – 2021)
• Worldwide Epilepsy Drugs Brand Market Performance (2013 – 2021)
• Epilepsy Drugs Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the Epilepsy Drugs Market

Key Epilepsy Drugs Covered in the Report are as follows:

1. Vimpat(Lacosamide)
2. Keppra(Levetiracetam)
3. Briviact(Brivaracetam)
4. Lamictal(Lamotrigine)
5. Neurontin (Gabapentin)
6. Depakine (Sodium Valproate)
7. Sabril (Vigabatrin)
8. Onfi(Clobazam)
9. Fycompa(Perampanel)
10. Inovelon/Banzel(Rufinamide)
11. Zonegran (Zonisamide)
12. Zebinix (Eslicarbazepine Acetate)

Key Companies Covered in the Report are as follows:

1. UCB
2. EISAI
3. Pfizer
4. Sanofi
5. Lundbeck

List of Tables

Table 3 1: Worldwide – Epilepsy Drugs Market Share(Percent),2013 – 2016
Table 3 2: Worldwide – Forecast for Epilepsy Drugs Market Share(Percent),2017 – 2021

Table 4 1: Epilepsy Branded Drugs Price List(US$),2017

Table 6 1: Collaboration Deals in Epilepsy Drug Market, 2008 – 2017
Table 6 2: Licensing Agreement in Epilepsy Drug Market, 2008 – 2016
Table 6 3: Partnerships Deals in Epilepsy Drug Market, 2008 – 2016

ABOUT Author:

Marketstatsreport.com is a market research report store for all type of industries. Market Stats Report has specialized research expertise in the areas of Healthcare, Agriculture, Semiconductor, Aviation, Defense, Automotive & Transport, Biotechnology, Chemicals & Materials, Consumer goods, Energy & Mining, Heavy Industry, Food & Beverages, Technology & Media, Pharmaceutical and Packaging. Our research reports provides in depth historical and forecast market analysis. Our reports cover accurate and real time-based business insights. We have collaborated with number leading market research players. Being one of the fastest growing market research reseller, we always focus on our client’s requirement and need. Market stats report supplies cutting edge market research reports across a wide range of industry verticals.

Market Stats Report: https://marketstatsreport.com/

Media Contact:

Contact Person: Alan Ruffalo

Contact us at: +1-800-977-4515 Phone: +91-7447409162

Email: sales@marketstatsreport.com, contact@marketstatsreport.com